Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M.T. Kalcioglu, I. Kuku, E. Kaya, S. Oncel & I. Aydogdu. (2003) Bilateral Hearing Loss During Vincristine Therapy: A Case Report. Journal of Chemotherapy 15:3, pages 290-292.
Read now
Read now
Articles from other publishers (19)
Angela Siemens, Beth Brooks, S. Rod Rassekh, Annelot J.M. Meijer, Mary M. van den Heuvel-Eibrink, Wei Xu, Catrina M. Loucks, Colin J.D. Ross & Bruce C. Carleton. (2023) Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. Therapeutic Drug Monitoring 45:3, pages 345-353.
Crossref
Crossref
James G. Naples, Wyatt Rice‐Narusch, Nathan W. Watson, Melissa Ghulam‐Smith, Sean Holmes, Daqing Li & Scharukh Jalisi. (2023) Ototoxicity Review: A Growing Number of Non–Platinum‐Based Chemo‐ and Immunotherapies. Otolaryngology–Head and Neck Surgery 168:4, pages 658-668.
Crossref
Crossref
Sven Strebel, Luzius Mader, Philippa Jörger, Nicolas Waespe, Seraina Uhlmann, Nicolas von der Weid, Marc Ansari & Claudia E. Kuehni. (2023) Hearing loss after exposure to vincristine and platinum-based chemotherapy among childhood cancer survivors. EJC Paediatric Oncology 1, pages 100017.
Crossref
Crossref
Melis Demirag Evman & Esra Turan Erkek. (2022) Does Chronic Immune Thrombocytopenia Lead to Hearing Loss?. Medical Science and Discovery 9:10, pages 577-580.
Crossref
Crossref
Annelot J. M. Meijer, Kathy H. Li, Beth Brooks, Eva Clemens, Colin J. Ross, Sharad R. Rassekh, Alex E. Hoetink, Martine van Grotel, Marry M. van den Heuvel‐Eibrink & Bruce C. Carleton. (2021) The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer 128:1, pages 169-179.
Crossref
Crossref
Kathleen C. M. Campbell & Colleen G. Le Prell. (2018) Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Safety 41:5, pages 451-464.
Crossref
Crossref
Charlotte Sleurs, Sabine Deprez, Louise Emsell, Jurgen Lemiere & Anne Uyttebroeck. (2016) Chemotherapy-induced neurotoxicity in pediatric solid non-CNS tumor patients: An update on current state of research and recommended future directions. Critical Reviews in Oncology/Hematology 103, pages 37-48.
Crossref
Crossref
임현곤, 최호석, 김규성 & 김민범. (2013) Sensorineural Hearing Loss Corrected by Thiamine Supply : A Case Report. Journal of Clinical Otolaryngology 24:2, pages 225-232.
Crossref
Crossref
K Pussegoda, C J Ross, H Visscher, M Yazdanpanah, B Brooks, S R Rassekh, Y F Zada, M-P Dub?B C Carleton & M R Hayden. (2013) Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children. Clinical Pharmacology & Therapeutics 94:2, pages 243-251.
Crossref
Crossref
Yoshinobu Hirose, Julian A. Simon & Henry C. Ou. (2011) Hair Cell Toxicity in Anti-cancer Drugs: Evaluating an Anti-cancer Drug Library for Independent and Synergistic Toxic Effects on Hair Cells Using the Zebrafish Lateral Line. Journal of the Association for Research in Otolaryngology 12:6, pages 719-728.
Crossref
Crossref
Anna K. Meyer & Nancy M. Young. 2009. Late Effects of Treatment for Brain Tumors. Late Effects of Treatment for Brain Tumors
195
213
.
Mufazzal Ahmad. (2007) Myeloma cast nephropathy presenting as acute onset bilateral reversible hearing loss. International Urology and Nephrology 39:3, pages 963-965.
Crossref
Crossref
Maria Riga, Stavros Korres, Ioannis Psarommatis, Maria Varvutsi, Ioannis Giotakis, Theodoros Papadas, Eleftherios Ferekidis & Nikolaos Apostolopoulos. (2007) Neurotoxicity of BFM-95 on the Medial Olivocochlear Bundle Assessed by Means of Contralateral Suppression of 2f1-f2 Distortion Product Otoacoustic Emissions. Otology & Neurotology 28:2, pages 208-212.
Crossref
Crossref
M. Riga, I. Psarommatis, S. Korres, M. Varvutsi, I. Giotakis, N. Apostolopoulos & E. Ferekidis. (2007) Neurotoxicity of vincristine on the medial olivocochlear bundle. International Journal of Pediatric Otorhinolaryngology 71:1, pages 63-69.
Crossref
Crossref
M. Riga, I. Psarommatis, S. Korres, Ch. Lyra, E. Papadeas, M. Varvutsi, E. Ferekidis & N. Apostolopoulos. (2006) The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions. International Journal of Pediatric Otorhinolaryngology 70:6, pages 1003-1008.
Crossref
Crossref
F. Block. 2006. Medikamentös induzierte neurologische und psychiatrische Störungen. Medikamentös induzierte neurologische und psychiatrische Störungen
289
302
.
John C. Bucuvalas, Amy O'Connor, Kristen Buschle, Susan Krug, Frederick C. Ryckman, Harry Atherton, Maria P. Alonso & William F. Balistreri. (2003) Risk of hearing impairment in pediatric liver transplant recipients: A single center study. Pediatric Transplantation 7:4, pages 265-269.
Crossref
Crossref
. (2001) Current Awareness. Pharmacoepidemiology and Drug Safety 10:4, pages 345-360.
Crossref
Crossref
&NA;. (2001) Vincristine. Reactions Weekly &NA;:841, pages 12.
Crossref
Crossref